Beijing
Beijing
Beijing, Bejing, China3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors | Advanced Solid Tumor | Recruiting | Phase 1 | 2026-09-18 | NCT06859762 | |
| Efficacy and Safety of Low-dose IL-2 in SLE Patients With CMV Viremia | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus | Not yet recruiting | Phase 2 | 2025-05-14 | NCT06971913 | |
| Phase III Clinical Study of MG-K10 Humanized Mab Injection in Subjects With Prurigo Nodularis | prurigo nodularis | Recruiting | Phase 3 | 2025-04-18 | NCT06779136 |